Brief: Biocartis Group Launches Idylla™ GeneFusion Assay
22/03/2021 06:24
March 22 (Reuters) - BIOCARTIS GROUP NV BCART.BR :
* PRESS RELEASE BIOCARTIS GROUP NV: BIOCARTIS LAUNCHES
IDYLLA™
GENEFUSION ASSAY AS RAPID LAB WORKFLOW SOLUTION FOR GENE FUSION
TESTING
Source text for Eikon: ID:nGNE38zGfQ
Further company coverage: BCART.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Biocartis NV
See all newsBrief: Biocartis Group NV Appoints Randy Polonsky As Chief Financial Officer
Brief: Biocartis Appoints New Chief Business Officer, VP Global Marketing
Brief: Biocartis And Merck To Collaborate
Brief: Biocartis's Secured Creditors Enforced Their Security Over Subsidiaries Shares
Brief: Biocartis Announces Expansion Of Its Collaboration With Apis Assay Technologies